Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection

BACKGROUND: At onset of coronavirus disease 2019 (COVID-19) pandemic, hydroxychloroquine (HCQ) was repurposed for treatment of patients based on reports that it had in vitro activity. The aim of this study was to find out if HCQ reduces number of days of hospitalization when given to patients with m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Med J Armed Forces India
Autores principales: Gupta, Salil, Dixit, Prashant Kumar, Ghana, Parthasarathi, Abhisheka, Kumar, Khurana, Harshit, Jha, Vijoy Kumar, Mahapatra, Debasish, Goel, Jitesh, Ahmed, Safia, Varadaraj, G.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313076/
https://ncbi.nlm.nih.gov/pubmed/34334898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.02.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares